PG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Term ID

CHEBI:89314

Synonyms

1-(9Z,12Z,15Z-Octadeatrienoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1'-glycerol)
1-a-Linolenoyl-2-docosahexaenoyl-sn-glycero-3-phosphoglycerol
1-alpha-Linolenoyl-2-docosahexaenoyl-sn-glycero-3-phosphoglycerol
[(2S)-2,3-dihydroxypropoxy][(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy]phosphinic acid
GPG(18:3/22:6)
GPG(18:3n3/22:6n3)
GPG(18:3w3/22:6w3)
GPG(40:9)
PG(18:3/22:6)
PG(18:3n3/22:6n3)
PG(18:3w3/22:6w3)
PG(40:9)
Phosphatidylglycerol(18:3/22:6)
Phosphatidylglycerol(18:3n3/22:6n3)
Phosphatidylglycerol(18:3w3/22:6w3)
Phosphatidylglycerol(40:9)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Phenotype where environments contain PG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Phenotype modified by environments containing PG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Human Disease Model